contractor articles (113)
Active Articles:
None to display.Retired Articles:
A484: Hyperbaric Oxygen (HBO) Therapy for the Treatment of Diabetic Wounds of the Lower ExtremitiesA619: Medicare Coverage of Levocarnitine for use in the treatment of Carnitine Deficiency in ESRD Patients
A715: Peripheral Neuropathy Coverage Policy and Billing Requirements Clarified
A748: Medicare Coverage of Rehabilitation Services for Beneficiaries with Vision Impairment
A892: Hospital Billing for Immunosuppressive Drugs Furnished to Transplant Patients (Part A)
A949: End Stage Renal Disease (ESRD) Claims Containing HCPCS Code J1955 (Levocarnitine) (Part A)
A951: Medical Nutrition Therapy (MNT) Services (Part A)
A1168: Elimination of Time Limit for Immunosuppressive Drugs (Part A and B)
A1248: Screening Glaucoma Services (Part A)
A2267: Supervising Physicians in Teaching Settings
A2349: Second Clarification of Medicare Policy Regarding the Implementation
A2411: Medical Nutrition Therapy (MNT) Services for Beneficiaries with Diabetes or Renal Disease
A4020: Skilled Nursing Facility Update from PrePay Medical Review
A6416: Educational Contact Update for Medical Review Process
A6434: Telehealth Update
A7203: Documentation Requirements for Partial Hospitalization Program (PHP) Services
A7645: Determining the Allowable for Drugs and Biologicals
A8414: Screening Mammography Services Billing
A9532: Heart Transplants
A9533: Draft LMRPs Available Soon on Web!
A9535: Oral Chemotherapy Drugs
A9682: Verteporfin Coverage
A11460: Electrical Osteogenic Stimulator Coverage Expanded
A11466: External Counterpulsation for Severe Angina Update
A11471: Oral Cancer Drugs Update
A11590: Need Help with Global and Multiple Surgery Modifiers?
A11595: Physician Order No Longer Required for Pneumococcal Vaccine
A11713: Questions and Answers about Outpatient Prospective Payment System
A15220: Diabetes Outpatient Self-Management Training Services (Part A)
A15221: Frequency of Billing (Part A)
A15300: Guidelines for Medicare Part B Laboratory Testing (Part A and B)
A15450: Wound Treatment by Electrical Stimulation
A15459: Positron Emission Tomography (PET) Scans Expaned Coverage
A15470: Stem Cell Transplantation
A15535: Expanded Coverage For PET Scans
A16877: Fecal-Occult Blood Tests (FOBT)
A16885: Signature Requirements
A18337: Intravenous Immune Globulin
A18585: Medicare Coverage Extended for Certain Colorectal Cancer Screening At Skilled Nursing Facilities (SNF)
A19018: Guidance for Handling Revenue Code 0910 (Part A)
A19152: Frequency Limitations for Darbepoetin Alfa (trade name Aranesp) for Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Dialysis (Part A and B)
A19694: Ocular Photodynamic Therapy (OPT) with Verteporfin for Age-Related Macular Degeneration (AMD) (Part A and B)
A20212: Electrical Stimulation and Electromagnetic Therapy for the Treatment of Wounds (Part A and B)
A20655: Discontinued Use of Revenue Code 0910 (Part A)
A20673: Diabetes Self-Management Training Services (Part A and B)
A20687: Emergency Hospital Outpatient Billing of Epotein Alfa (EPO) and Darbepoetin Alfa (Aranesp) (Part A)
A20925: Coding of Subsequent Hospital Care
A21037: End Stage Renal Disease (ESRD) Reimbursement for Automated Multi-Channel Chemistry (AMCC) Tests (Part A)
A23882: Magnetic Resonance Spectroscopy (MRS) for Diagnosing Brain Tumors
A23894: Percutaneous Transluminal Angioplasty (PTA)
A24123: Medicare Termination of Beneficiaries with End Stage Renal Disease (ESRD)
A24873: Drug Administration Coding Changes and Reimbursement
A24878: Inclusion of Forteo as a Covered Osteoporosis Drug and Clarification of Manual Instructions Regarding Osteoporosis Drugs
A24907: Low Osmolar Contrast Material/Laboratory Tests/Payment for Inpatient Services Furnished by a Critical Access Hospital
A25110: Diabetes Screening Tests
A25116: Electrocardiographic Services
A25350: Medical Review (MR) of Rural Air Ambulance Services
A25357: Update to Billing Requirements for Positron Emission Tomography (PET) Scans for Dementia and Neurodegenerative Diseases and Update for Special Payment Procedures for all PET Scan Services Performed in Critical Access Hospitals
A26254: IRF Probe Re-determination Review Results
A26262: Psychotherapy Notes
A27571: Infusion Pumps: C-Peptide Levels as a Criterion for Use
A33868: Rhode Island Part A Laboratory CERT Errors
A34377: New HCPCS Codes for Intravenous Immune Globulin (IVIG)
A34380: Expanded Coverage for PET Scans for Cervical and Other Cancers, New Coding for PET Scans, and Billing Requirements for PET Scans for Specific Indications of Cervical and Other Cancers
A34787: Widespread Prepay Probe Reviews Planned for Arkansas and Rhode Island for TOB 22X and 23 X
A35849: Mass Adjustment of Certain Transplant Claims
A37755: Radiopharmaceutical Diagnostic Imaging Agents Codes Applicable to PET Scan Services Performed on or After January 28, 2005
A37792: Medical Nutrition Therapy Services
A37904: Inpatient Rehabilitation Facility Widespread Follow-up Probe Planned
A39122: Widespread Prepay Probe Review Results for CPT/HCPCS Code 82962 Billed on TOB 22X and 23X
A41335: Services Not Provided Within the United States
A41344: Guidelines for Payment of Vaccines (Pneumococcal Pneumonia Virus (PPV), Influenza Virus, and Hepatitis B Virus) and Their AdministrationOperated Hospitals and Hospital-Based Facilities
A42207: Widespread Prepay Probe Review Results for TOB 23X Rev Code 042X, 043X and 044X
A42580: Inpatient Rehabilitation Facility Widespread Probe Part A
A42593: Skilled Nursing Facility (SNF) Swing Bed Widespread Prepay Probe Documentation Requirements
A42594: Widespread Prepay Probe Planned for SNF Swing Bed Services TOB 18x Advisory
A42682: Probe Review Results of Hospital Outpatient Physical Therapy Services in Arkansas
A42684: SNF Widespread Prepay Probe for Swing Bed Services TOB 18x; Advisory: Notice of Correction
A42688: Inpatient Rehabilitation Facility Widespread Probe Part A
A42697: Notice of PROBE for EPO/Aranesp Services for Secondary Anemia: Advisory
A42711: Results of Widespread Prepay Probe Review for Hospital Swing Bed Services in Arkansas
A45490: CERT Medical Record Requests
A45492: CERT Process Overview
A45515: Widespread Probe Review Results – EPO/Darbepoetin Alfa Administration
A46143: ADVISORY: Notification of Upcoming Widespread Probe on TOB 13X, Revenue Codes 0401 (Diagnostic Mammography) and 0403 (Screening Mammography)
A46258: Required Documentation Advisory
A46271: Skilled Nursing Facility: Probe Follow-Ups
A46295: ADVISORY: Notification of Upcoming Widespread Probe on TOB 85X, Revenue Code 098x
A46354: Probe Review Results for Arkansas Computerized Tomography (CT
A46357: Probe Review Results for Arkansas Magnetic Resonance Imaging
A46392: Prepay Probe Review Results: Arkansas Mammography, TOB 13X
A46448: Notification of Upcoming Widespread Probe on TOB 13X,
A46498: Prepay Probe Review Results: Arkansas – Professional Fees Related
A46503: Required Documentation Advisory
A47423: ADVISORY: Notification of Upcoming Widespread Probe on TOB 13X, Revenue Code 045X
A48253: Status of Complex Review of Skilled Nursing Facilities (SNF) in Arkansas and Rhode Island
A48376: Prepay Probe Review Results: Arkansas Emergency Room Visit Codes, TOB 13X, Revenue Codes 045X
A49226: Comprehensive Error Rate Testing (CERT) What is the Financial Impact to You?
A49227: Provider Specific Prepay Probe Review Results - Erythropoietin Stimulating Agents (ESA), Non-Renal, TOB 13X, Revenue Code 0636,HCPCS codes J0881 and J0885
A49276: ADVISORY: Notification of Upcoming Widespread Probe on Type of Bill (TOB) 85X, Revenue Codes 042X, 043X, and 044X
A49564: Widespread Probe Review Results for Critical Access Hospitals (TOB85X) and Therapies (Revenue codes 042X, 043X, 044X)
A49568: Widespread Prepay Probe Review Results for TOB 23X Rev Codes 042X, 043X and 044X
A49906: CERT Error Rates Released by CMS